Arch Oncology Alternatives & Competitors
12 companies similar to Arch Oncology
Companies similar to Arch Oncology
Tarveda Therapeutics
To discover, develop and commercialize a new class of potent and selective precision oncol...
Watertown, United States
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Toronto, Canada
Acepodia
POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER
Alameda, United States
Harpoon Therapeutics
SPEARHEADING IMMUNOTHERAPIES
South San Francisco, Unit...
Track all Arch Oncology competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
Compass Therapeutics Inc.
We are developing next-generation antibodies into transformative cancer therapies that imp...
Boston, United States
Jounce Therapeutics, Inc.
Daring to create a world immune to cancer.
Cambridge, United States
Merus N.V.
Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community...
Utrecht, The Netherlands
ALX Oncology
ALX Oncology is a clinical-stage biotechnology company advancing cancer therapies by boost...
South San Francisco, Unit...
Aulos Bioscience
We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immune...
Larkspur, United States
Abcuro, Inc
Developing immunotherapies for autoimmune diseases and cancer
About Arch Oncology
Arch Oncology is a biotechnology company founded in 2006 and based in the United States. The company is primarily focused on developing groundbreaking antibody therapies for the treatment of solid tumors and hematologic malignancies. Their lead product candidate AO-176 is currently in Phase 1/2 clinical trials for the...
Immuno-oncology, Antibody Therapies, Clinical-stage, Phase 1/2 Trials, Solid Tumors, Hematologic Malignancies, Anti-CD47 Antibodies, Cancer Treatment, Drug Development, Macrophages, St. Louis, MO, Brisbane, CA, Tumor Microenvironment, Scientific Research
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Arch Oncology and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Arch Oncology on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
